Terapia extracorporea di magnetotrasduzione (EMTT): MAGNETOLITH DI STORZ MEDICAL riceve la clearance 510(k) dalla FDA

MAGNETOLITH_002

Il 3 maggio 2021, STORZ MEDICAL ha ricevuto dalla Food and Drug Administration (FDA) statunitense la clearance 510(k) per il MAGNETOLITH®. Il dispositivo terapeutico è ora pre-approvato negli Stati Uniti (come dispositivo medico di classe II) per le seguenti indicazioni:

  • Rilassamento degli spasmi muscolari
  • Prevenzione o ritardo dell'atrofia da disuso
  • Aumento della circolazione sanguigna locale
  • Rieducazione muscolare
  • Stimolazione post-chirurgica immediata dei muscoli del polpaccio per prevenire la trombosi venosa
  • Mantenimento o aumento della gamma di movimento
Continua a leggere
0
  59 Visite
  0 Commenti
59 Visite
0 Commenti

100 devices in 7 months: STORZ MEDICAL has successfully launched MAGNETOLITH

2020-10-13_news_Magnetolith_Dr_Goerner

In September 2020, the 100th MAGNETOLITH® was ordered and delivered to Dr Damian Görner from the Steglitz Spine and Joints Centre in Berlin. In an interview, the specialist for orthopaedics and trauma surgery explains why he decided to use MAGNETOLITH®, which indications he treats and how EMTT® and ESWT complement each other.

Continua a leggere
0
  1543 Visite
  0 Commenti
1543 Visite
0 Commenti

STORZ MEDICAL’s MAGNETOLITH receives CE approval

2020-02-24_001_news

In February 2020, STORZ MEDICAL has received the CE approval for the MAGNETOLITH® system, which is the successor of the CELLACTOR® MT1. Extracorporeal Magnetotransduction Therapy (EMTT®) with the MAGNETOLITH® opens up new possibilities in regeneration and rehabilitation. The areas of application include diseases of the musculoskeletal system such as lower back pain and tendinopathies of the rotator cuff or Achilles tendon. The non-invasive, outpatient therapy is virtually free of side effects.

Continua a leggere
2
  4902 Visite
  0 Commenti
4902 Visite
0 Commenti

MEDICA 2019: STORZ MEDICAL presents new innovations NEUROLITH, MAGNETOLITH and redesigned MODULITH SLC

2019-11-26_news_MEDICA

Düsseldorf/Germany: After three fascinating and very interesting days, MEDICA 2019 ended on 21 November. Once again, the world’s leading medical trade fair was a huge success. At STORZ MEDICAL’s exhibition stand in hall 10, the full range of the company’s therapy options was on display – including several innovations. Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system, a unique procedure for patients with Alzheimer's disease, was explained in detail by Dr Rafael Storz, who also answered the visitors’ questions. In addition, the new MAGNETOLITH® for Extracorporeal Magnetotransduction Therapy (EMTT®) and the redesigned MODULITH® SLC were also at the centre of attention. Both devices were unveiled and presented during the trade fair.

Continua a leggere
1
  5191 Visite
  0 Commenti
5191 Visite
0 Commenti
Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel